Our study proposes that intratumoral injection of an unadjuvanted seasonal influenza vaccine reduces tumor growth by converting immunologically inactive cold tumors to immune-infiltrated hot tumors, by augmenting DCs (including cross-presenting DCs) and tumor antigen-specific CD8+ T cells within the tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.